EyePoint (EYPT) vs Rapid Micro Biosystems (RPID)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
EyePoint (EYPT) has outperformed Rapid Micro Biosystems (RPID) over the past year, losing 74.9% versus a loss of 75.7%. Over five years, EYPT leads with a -71.0% price change compared with -94.7% for RPID. EyePoint is the larger company by market cap ($282.1 million vs $42.4 million), about 6.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EYPT | RPID |
|---|---|---|
| Share price | $3.37 | $0.8452 |
| Market cap | $282.13M | $42.39M |
| 1-day change | +1.36% | -5.85% |
| YTD return | -81.83% | -69.04% |
| 1-year return | -74.94% | -75.67% |
| 5-year return | -70.98% | -94.66% |
| EPS (TTM) | $-3.75 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.11 | $4.94 |
| 52-week low | $3.05 | $0.8411 |
| Distance from 52-week high | -82.39% | -82.89% |
| Analyst consensus | none | — |
| Avg. price target upside | +669.99% | — |
| Average volume | 3.93M | 271.81K |
| Shares outstanding | 83.84M | 45.66M |
| Employees | 214 | — |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EyePoint is about 6.7 times larger than Rapid Micro Biosystems by market value ($282.13M vs $42.39M).
About EyePoint
EYPT stock →EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Industrials · Biotechnology: Laboratory Analytical Instruments · 214 employees
EYPT vs RPID FAQ
Which is bigger, EyePoint or Rapid Micro Biosystems?
EyePoint (EYPT) is larger, with a market capitalization of $282.13M compared with $42.39M for Rapid Micro Biosystems (RPID).
Which stock has performed better over the past year, EYPT or RPID?
EYPT returned -74.94% over the past 12 months, compared with -75.67% for RPID (price return, excluding dividends). Past performance does not predict future results.
Are EyePoint and Rapid Micro Biosystems in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.